$20.68
-0.14-0.67%
In chiusura: -
$20.68
0.000.00%
After hour: 4:00 PM EDT
Enliven Therapeutics segnala gli utili su base trimestrale. Questi report sugli utili trimestrali offrono agli investitori uno sguardo ai risultati finanziari di un'azienda per un periodo di 3 mesi. I report sugli utili includono quasi sempre i risultati EPS e i ricavi.
Analizza lo storico degli utili di Enliven Therapeutics utilizzando ordinamenti e filtri avanzati.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
ELVN | Enliven Therapeutics | -$0.48 | -$0.44 | — | — | $0.00 | — | — | — | 11/12/2025 | |
ELVN | Enliven Therapeutics | -$0.41 | -$0.46 | -$0.49 | -6.52% | $0.00 | — | $0.00 | — | 08/13/2025 | |
ELVN | Enliven Therapeutics | -$0.54 | -$0.56 | -$0.57 | -1.79% | $0.00 | — | $0.00 | — | 05/14/2025 | |
ELVN | Enliven Therapeutics | -$0.47 | -$0.52 | -$0.46 | 11.54% | $0.00 | — | $0.00 | — | 03/13/2025 | |
ELVN | Enliven Therapeutics | -$0.51 | -$0.50 | -$0.48 | 4.00% | $0.00 | — | $0.00 | — | 11/13/2024 | |
ELVN | Enliven Therapeutics | -$0.41 | -$0.55 | -$0.41 | 25.45% | $0.00 | — | $0.00 | — | 08/13/2024 | |
ELVN | Enliven Therapeutics | -$0.80 | -$0.57 | -$0.54 | 5.26% | $0.00 | — | $0.00 | — | 05/14/2024 | |
ELVN | Enliven Therapeutics | -$0.08 | -$0.54 | -$0.47 | 12.96% | $0.00 | $0.00 | $0.00 | — | 03/14/2024 | |
ELVN | Enliven Therapeutics | -$0.72 | -$0.47 | -$0.51 | -8.51% | $0.00 | — | $0.00 | — | 11/09/2023 | |
ELVN | Enliven Therapeutics | -$1.76 | -$0.36 | -$0.41 | -13.89% | $0.00 | — | $0.00 | — | 08/10/2023 | |
ELVN | Enliven Therapeutics | -$2.24 | -$0.63 | -$0.80 | -26.98% | $0.00 | — | $0.00 | — | 05/11/2023 | |
ELVN | Enliven Therapeutics | — | — | -$0.08 | — | — | — | $0.00 | — | 02/10/2023 | |
ELVN | Enliven Therapeutics | — | — | -$0.72 | — | — | — | $0.00 | — | 10/25/2022 | |
ELVN | Enliven Therapeutics | — | — | -$1.76 | — | — | — | $0.00 | — | 08/03/2022 | |
ELVN | Enliven Therapeutics | — | — | -$2.24 | — | — | — | $0.00 | — | 05/06/2022 | |
ELVN | Enliven Therapeutics | — | -$3.00 | -$2.12 | 29.33% | — | — | $0.00 | — | 03/15/2022 | |
ELVN | Enliven Therapeutics | — | -$5.12 | -$2.20 | 57.03% | — | — | $0.00 | — | 11/09/2021 | |
ELVN | Enliven Therapeutics | — | -$3.20 | -$2.96 | 7.50% | — | — | $0.00 | — | 08/06/2021 | |
ELVN | Enliven Therapeutics | — | -$3.32 | -$2.32 | 30.12% | — | — | $0.00 | — | 05/11/2021 | |
ELVN | Enliven Therapeutics | — | -$3.36 | -$2.24 | 33.33% | — | — | $0.00 | — | 03/05/2021 | |
ELVN | Enliven Therapeutics | — | — | -$2.88 | — | — | — | $0.00 | — | 11/05/2020 |
Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
---|---|---|---|---|
Q2 | 2025-08-13 | $-0.49 | $-0.46 | -6.52 % |
Q1 | 2025-05-14 | $-0.57 | $-0.56 | -1.79 % |
Q4 | 2025-03-13 | $-0.46 | $-0.52 | 11.5 % |
Q3 | 2024-11-13 | $-0.48 | $-0.50 | 4.00 % |
Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
---|---|---|---|---|
Si prevede che Enliven Therapeutics (ELVN) fornisca risultati il novembre 12, 2025. Gli ultimi risultati sono stati pubblicati il agosto 13, 2025 per il Q2.
L'EPS effettivo era $-0.49, che mancato la stima di $-0.46.
Le entrate effettive sono state $0K, che centrato la stima di $0K.
Sfoglia stime sugli utili, EPS e ricavi su tutte le azioni.